On October 19, 2022, the U.S. Advisory Committee on Immunization Practices (ACIP) recommended the use of either a dose of 20-valent pneumococcal conjugate vaccine (PCV20) or 23-valent pneumococcal polysaccharide vaccine (PPSV23) as previously recommended for adults who have received 13-valent pneumococca...
This guideline covers recognition, referral, investigation and management of spinal metastases and metastatic spinal cord compression (MSCC). It is also relevant for direct malignant infiltration of the spine and associated cord compression. It aims to improve early diagnosis and treatment to prevent neu...
Kobayashi, Miwako;
Pilishvili, Tamara;
Farrar, Jennifer L;
Leidner, Andrew J;
Gierke, Ryan;
Prasad, Namrata;
Moro, Pedro;
Campos-Outcalt, Doug;
Morgan, Rebecca L;
Long, Sarah S;
Poehling, Katherine A;
Cohen, Adam L.
his report compiles and summarizes all published recommendations from CDC’s Advisory Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults aged ≥19 years in the United States. This report also includes updated and new clinical guidance for implementation from CDC.
Bef...
This guideline covers the care of women and their babies during labour and immediately after birth. It focuses on women who give birth between 37 and 42 weeks of pregnancy (‘term’). The guideline helps women to make informed choices about where to have their baby and about their care in labour. It al...
A Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) review of the evidence for benefits and harms of the long-acting monoclonal antibody nirsevimab, (Beyfortus, Sanofi and AstraZeneca) for prevention of respiratory syncytial virus (RSV)-associated lower respiratory tract infecti...
A Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) review of the evidence for benefits and harms for the long-acting monoclonal antibody nirsevimab, (Beyfortus, Sanofi and AstraZeneca) for prevention of respiratory syncytial virus (RSV))-associated lower respiratory tract infec...
Most of the influenza vaccines currently approved and available in the United States are produced by the propagation of influenza viruses in eggs (1-7). These vaccines therefore can contain small quantities of egg proteins. As of the 2022-23 influenza season, ACIP has recommended annual influenza vacci...
Scully, M;
Rayment, R;
Clark, A;
Westwood, J. P;
Cranfield, T;
Gooding, R;
Bagot, C. N;
Taylor, A;
Sankar, V;
Gale, D;
Dutt, T;
McIntyre, J;
Lester, W.
The objective of this guideline is to provide healthcare professionals with clear, up-to-date and practical guidance on the management of thrombotic thrombocytopenic purpura (TTP) and related thrombotic microangiopathies (TMAs), including complement-mediated haemolytic uraemic syndrome (CM HUS); these ar...
Thrombotic Microangiopathies/diagnosis,
Purpura, Thrombotic Thrombocytopenic/diagnosis,
Antibodies, Monoclonal/therapeutic use,
Immunization, Passive,
Blood-Derivative Drugs,
Thrombotic Microangiopathies/therapy,
Purpura, Thrombotic Thrombocytopenic/therapy
Seth, Rahul;
Agarwala, Sanjiv S;
Messersmith, Hans;
Alluri, Krishna C;
Ascierto, Paolo A;
Atkins, Michael B;
Bollin, Kathryn;
Chacon, Matias;
Davis, Nancy;
Faries, Mark B;
Funchain, Pauline;
Gold, Jason S;
Guild, Samantha;
Gyorki, David E;
Kaur, Varinder;
Khushalani, Nikhil I;
Kirkwood, John M;
McQuade, Jennifer Leigh;
Meyers, Michael O;
Provenzano, Anthony;
Robert, Caroline;
Santinami, Mario;
Sehdev, Amikar;
Sondak, Vernon K;
Spurrier, Gilliosa;
Swami, Umang;
Truong, Thach-Giao;
Tsai, Katy K;
van Akkooi, Alexander;
Weber, Jeffrey.
To provide guidance to clinicians regarding the use of systemic therapy for melanoma.
American Society of Clinical Oncology convened an Expert Panel and conducted an updated systematic review of the literature.
The updated review identified 21 additional randomized trials.
Neoadjuvant pembrolizumab was n...
Introduction
The first aim of this study was to compare synchronous and asynchronous telerehabilitation programs in COVID-19 survivors with classes 4–6 and determine the more appropriate telerehabilitation approach.
Methods
Thirty-six COVID-19 survivors with class 4–6 severity were randomly divided i...
